Most common origin of intra-abdominal infections in children is appendicitis. Microorganisms responsible for communitybased and hospital-acquired intra-abdominal infections vary. Complicated appendicitis, gastrointestinal system perforations, intraabdominal abscess and diverticula are the most common causes of community-based infections.
In those infections, site of gastrointestinal perforation (stomach, duodenum, jejunum, ileum, appendix or colon) determines the infectious flora. E. coli, Proteus spp., Klebsiella spp., Enterobacter spp. and occasionally P. aeruginosa are responsible for the infections of duodenum and farther jejunum; whereas anaerobic bacteria such as B. fragilis, Clostridium spp., or Fusobacterium spp. may be included in farther ileum as well. 1, 2 With the introduction of wide spectrum systemic intravenous antibiotics usage in the treatment of appendicitis, rates of mortality and morbidity have reduced dramatically 3 .
Additionally, it has been demonstrated that nonsurgical medical treatment of non-complicated appendicitis was possible in children. 4, 5 Extended-spectrum β-lactamases (ESBLs) are being used at increasing rates worldwide, and therefore surveillance studies have gained importance. 6 Resistance of bacteria should be monitored for the definition of empirical antibiotic therapy protocols.
The aim of this study was to evaluate microbial culture outcomes and antibiotic susceptibilities of these microorganisms in samples obtained intraoperatively from pediatric patients with appendicitis, and to define the infectious microorganisms responsible for the communitybased intra-abdominal infections in our region, and their antibiotic susceptibilities. Our study is important to contribute to a local consensus on empirical antibiotic regimen in communitybased intra-abdominal infections in both patients operated due to appendicitis and community-based intra-abdominal infections.
Material and Methods

Study population and design
The study protocol was approved by the Ethics Committee of our institute (date: 22/03/2016, report number: 06/24) and written or verbal consent was obtained from the parents of all participants. This study was planned as a prospective study. This study included 231 patients between 0 and 16 years of age, operated in the Pediatric Surgery Department of Fırat University due to appendicitis between September 2014 and September 2017. Children with previous abdominal operations, antibiotic usage within the recent 3 months and those with a history of hospitalization were excluded. Follow-up forms were created for the patients. Forms included information on the age and gender of the patients, intra-abdominal event (abscess formation, acute appendicitis, suppurative appendicitis, perforated appendicitis), bacterial growth in microbial culture and antibiogram, antibiotic switch during follow-up, duration of the treatment, complications and outcomes were recorded. Appendicular tissues were sampled intraoperatively and sent to laboratory. Samples were inoculated into blood agar and Eosin-Metylene Blue (EMB) agar plaques, incubated at 37°C for 72 hours. Examinations were performed at 24 th , 48 th and 72 nd hours.
Bacterial identification and antimicrobial susceptibility testing
All of the samples were analyzed in the clinical laboratory of Firat University Hospital (Elazig, Turkey). For bacterial identification, the isolates were analyzed by automated VITEC-2 compact system (Biome´rieux, France). To assess antimicrobial susceptibility, the minimum inhibitory concentrations (MICs) of ceftriaxone, ceftazidime (CAZ), cefotaxime (CTX), ertapenem, imipenem, ampicillin-sulbactam, piperacillin-tazobactam, amikacin, ciprofloxacin, and co-trimoxazole were determined using dehydrated MicroScan broth microdilution panels (Siemens Medical Solutions Diagnostics, West Sacramento, CA, USA) according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI). 7 Susceptibility interpretations were based on the CLSI M100-S23 clinical breakpoints. 8 We used the ATCC 25922 strain of E. coli, the ATCC 27853 strain of P. aeruginosa, and the ATCC 700603 strain of Klebsiella spp. as reference strains in each set of MIC tests for quality control. We determined the susceptibilities of coagulase-negative staphylococci (CNS), isolates to vancomycin, linezolid, oxacillin, and daptomycine by E-test method. We determined the susceptibilities of Enterococcus spp., and Streptococcus spp. isolates to vancomycin, linezolid, and daptomycine by E-test method and we determined the MIC of the strains.
Detection of extended-spectrum β-lactamase
Phenotypic identification of ESBL-producing strains of E. coli, Klebsiella spp. was performed according to the CLSI recommendations 8 . We defined ESBL production as a decrease in the MICs for CTX and CAZ of >8-fold when tested in combination with clavulanic acid relative to the MICs for CTX and CAZ in the absence of clavulanic acid.
Statistical analysis
Data were analyzed using the IBM Statistical Package for Social Sciences v22 (SPSS Inc.,
Volume 60 • Number 5 Community-Based Intra-abdominal Infections and Microbial Resistance Profile
Chicago, IL, USA). Parametric tests (Chisquare and Fisher's exact chi-square tests) were applied to data of normal distribution and non-parametric tests (T-test, Mann-Whitney and Wilcoxon tests) were applied to data of questionably normal distribution. Continuous data were presented as mean±standard deviation. All differences associated with a chance probability of 0.05 or less were considered statistically significant.
Results
A total of 231 patients had undertaken appendectomy during the study period. Table II .
Methicillin resistance was detected in 2 of CNS (33.3%). In 1 of these strains, linezolid and daptomycin resistance were observed as well. In 1 of the 3 enterococci grown (33.3%) (E. raffinosus), vancomycin and linezolid resistance were observed. The streptococcus strain detected in 1 patient was found to be susceptible to penicillin and other antimicrobial agents.
No complication was observed in 215 (93.1%) patients, superficial surgical site infection was observed in 10 (4.3%), intra-abdominal abscess was observed in 1 (0.4%), intraabdominal abscess+ileus were observed in 1 (0.4%), ileus was observed in 2 (0.9%) and superficial surgical site infection+ileus were observed in 2 (0.9%) (Table III) . Complications were observed in 13 of 70 patients with perforated appendicitis in, 2 of 117 patients with suppurative appendicitis and 1 of 44 patients with acute appendicitis.
Cefazolin+metronidazole were used for surgical prophylaxis in acute and suppurative appendicitis. When the source control was sufficient in perforated appendicitis, treatment of cefotaxim+metronidazole was started for 4-7 days. Antibiotic revision was made in 3 patients due to the complications observed under initial antibiotic therapy. Among those, E. coli growth was detected in all of them and ESBL positivity was detected in two of them. Intra-abdominal abscess was observed in both of these patients. Two cases belonged to the perforated appendicitis group. One patient had a concomitant ileus. Antibiotic revision was made in one patient with superficial wound site infection as well. Patients with ESBL positive E. coli growth were compared to those with 
Data is presented as n (%) abdominal sampling for microbial culture is recommended during drainage, in order to select a highly tolerated and safe agent with a limited spectrum during gradual reduction of the oral therapy (B-II). In cases with no response to the treatment and continued infection, anaerobic microbial culturing is recommended (C-III) 9 . Recommendations in the recent guidelines published by both Surgical Infection Society and World Emergency Surgery Society are parallel to those in the guidelines of IDSA 10, 11 . No study has so far been conducted in our region on the causes of communitybased intra-abdominal infections and antibiotic susceptibility of these agents other than our previous study on 44 pediatric patients. 12
In our study, E. coli growth was observed in 139 (79.9%) patients and ESBL positivity was detected in 51 (36.7). In a previous study conducted in the Marmara region of our country, 33 pediatric patients with perforated appendicitis were evaluated and E. coli growth was observed in 26 (87%) patients, and ESBL positivity was detected in 8 (31%). 13 Resistance rates among gram negative bacteria are increasing each day. The recent, as well as largest study conducted on the subject was SMART, which included data from 44 hospitals of 16 countries from Europe. A total of 1259 strains of infectious intra-abdominal agents were included in the study in the pediatric patient group. 14 Among communitybased infections, E. coli was detected at a rate of 75.4% which was similar to our study. However, in community-based strains of E. coli, ESBL positivity was observed to be 5.5%. The reason for that may be the collection of the data for the strains in SMART study between 2011 and 2014, and their increasing resistance within years. However, in community-based infections, this rapid increase in the resistance may be improper antibiotic therapy as well. In another study conducted in Pacific Island, intraabdominal microbial cultures of 144 cases with perforated appendicitis including 47 pediatric patients, were evaluated 15 . Microbial growth was detected in 74% of the samples, which was similar to the rate in our study. In 81% of the cases with microbial growth, E. coli was the isolated agent. ESBL positivity was not investigated. In a multi-center study conducted in China, gram negative bacteria isolated from patients with intra-abdominal infection, and their susceptibilities were investigated between 2012 and 2013. 16 Community-based intraabdominal infection cause of ESBL positive E.coli was detected at a rate of 55.6%. The rate of community-based ESBL positive E. coli among cases with intra-abdominal infectionrelated appendicitis was 46%. In a study investigating the microbial culture results of pediatric patients with appendicitis in Ireland, E. coli was found to be the infectious agent at a rate of 81% and no ESBL positivity was detected 17 . However, data of the study belonged to years 1995-2008. Many risk factors have been defined for ESBL positivity in pediatric patients. These include low birth weight, stay in pediatric or newborn intensive care unit, histories of invasive intervention, delayed intubation time or antibiotic therapy. [18] [19] [20] [21] [22] However, our patients were community-based and those with any type of antibiotic therapy 3 months prior to the treatment were excluded. High ESBL positive E. coli rates observed in our study, despite this fact may, be due to the frequent usage of antimicrobial agents in the childhood and to the recent nature of our data. It has been Data is presented as n (%) emphasized in a study that ESBL positive enterobactericia could be transmitted from the child to other individuals in the house in cases it has been carried more than 4 years, and in turn it might contribute to an ESBL positivity spread in the community. 23 As mentioned, significant differences are observed between centers, which demonstrates the importance of interregional variability.
Another important aspect of our study is the low number of cases necessitating antibiotic revision despite high ESBL positivity rates. Importance of source control is obvious at that point. 10 In patients with communitybased intra-abdominal infection and low risk, and when satisfactory clinical outcome is observed via source control and initial therapy, afterwards no antibiotic revision is needed even in the presence of the pathogens not suspected and treated at the beginning (B-III).
In our study, antibiotic revision was needed in only 3 patients since all were operated due to appendicitis with previous source control and good clinical response. However, high rates of resistance should be considered and empirical therapy should be started in patients with acute appendicitis, who are planned to be given medical treatment only. When a 10-20% or higher resistance is observed to the isolates of a frequent intra-abdominal pathogen, this antibiotic agent should not be used. Ampicilinsulbactam and ciprofloxacin usage is not recommended. According to our data, although fluoroquinolone usage is common among pediatric patients in our country, resistance of E. coli to ciprofloxacin was found to be 20.86%.
Resistance to ampicillin-sulbactam was found to be 83.45%. Likewise, co-trimoxazole should not be used due to high resistance.
Ertapenem, which is known to be effective i n c o m m u n i t y -b a s e d E S B L p o s i t i v e microorganisms, is an important alternative in intra-abdominal infections. Its potential to be used alone in intra-abdominal infections is an important advantage. No efficacy on P. aeruginosa may be counted as a disadvantage, however, this microorganism is not common among community-based infections. 10 Ertapenem was considered to be safe and effective in the empirical treatment of community-based intraabdominal infections in patients especially not considered for surgery and who admit with a septic presentation.
As a conclusion, our study clearly demonstrates that the resistance profile varies in communitybased intra-abdominal infections. Empirical treatment protocols should be revised in especially the patients admitted with septic presentation and where the source control is not possible. The fact that our study is the only central data center and the small number of complication rates, restricts the evaluation of effect of resistance on clinical outcomes.
Further studies with larger sample sizes are needed on the subject.
